Govt Promotes R&D in Pharma Medtech Sector with AI Integration
ECONOMY & POLICY

Govt Promotes R&D in Pharma Medtech Sector with AI Integration

The Department of Pharmaceuticals (DoP) has launched initiatives to enhance research and development (R&D) in the pharmaceutical sector, particularly in artificial intelligence (AI) and machine learning, through the Scheme for Promotion of Research and Innovation in the Pharma Medtech Sector. As part of these efforts, the National Institutes of Pharmaceutical Education and Research (NIPER), under DoP, have incorporated AI and blockchain technology into their academic curriculum and are training students in AI-based tools to strengthen human resource capabilities in the sector. 

Additionally, the Department of Biotechnology is supporting AI-driven research in biotechnology, with a focus on healthcare and agriculture, to leverage emerging technologies for these critical industries. The Pharmaceuticals and Medical Devices Bureau of India, in collaboration with the Centre for Development of Advanced Computing, has also initiated a pilot project to assess the feasibility of a blockchain-based track-and-trace system for the Pradhan Mantri Bhartiya Janaushadhi Pariyojana. 

This information was provided by Union Minister of State for Chemicals and Fertilisers, Smt. Anupriya Patel, in a written reply to a question in the Rajya Sabha. 

(PIB)          

The Department of Pharmaceuticals (DoP) has launched initiatives to enhance research and development (R&D) in the pharmaceutical sector, particularly in artificial intelligence (AI) and machine learning, through the Scheme for Promotion of Research and Innovation in the Pharma Medtech Sector. As part of these efforts, the National Institutes of Pharmaceutical Education and Research (NIPER), under DoP, have incorporated AI and blockchain technology into their academic curriculum and are training students in AI-based tools to strengthen human resource capabilities in the sector. Additionally, the Department of Biotechnology is supporting AI-driven research in biotechnology, with a focus on healthcare and agriculture, to leverage emerging technologies for these critical industries. The Pharmaceuticals and Medical Devices Bureau of India, in collaboration with the Centre for Development of Advanced Computing, has also initiated a pilot project to assess the feasibility of a blockchain-based track-and-trace system for the Pradhan Mantri Bhartiya Janaushadhi Pariyojana. This information was provided by Union Minister of State for Chemicals and Fertilisers, Smt. Anupriya Patel, in a written reply to a question in the Rajya Sabha. (PIB)          

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code